In 2023, Vetoquinol Celebrates Its 90th Anniversary
19 Juni 2023 - 5:45PM
Business Wire
Recalling a memorable anniversary day
Regulatory News:
The Vetoquinol (Paris:VETO) saga started 90 years ago in the
back office of the Frechin family pharmacy in Lure, Franche Comté
(East of France). The company is now among the top 10 animal health
companies in the world, nine decades and three generations later,
but its DNA is still rooted in Lure, in this Haute-Saône
village.
Over 700 current and former employees and retirees of the
company from Lure and all over France gathered there on June 16,
2023, to commemorate the 90th anniversary of Vetoquinol. Around the
world all 2,500 members of Vetoquinol workforce participated in an
international celebration of this anniversary on the same day. To
celebrate this exceptional year with the 24 affiliates of the
group, video conferences have been organized.
To start, all the French participants gathered at 5 p.m. in Lure
for a welcome cocktail and a welcome speech from Matthieu Frechin,
the company's general manager. The Group Chairman, Etienne Frechin,
spoke after him.
To illustrate the transition between the past and present time
three pairs, each made up of a working person and a retired person,
have also shared their experiences while highlighting the
differences and similarities between earlier work operations and
current ones.
Vetoquinol employees then got together to put on a collective
performance, creating a human Vetoquinol logo and the number
90.
The guests then took part in a giant banquet. It was quite a
feat of gastronomy and logistics, where everyone enjoyed this
enchanted moment, punctuated by a superb birthday cake and the
unveiling of a commemorative sculpture.
The evening continued in a festive atmosphere on the dance floor
and around the various recreational workshops, from m�lkky to
babyfoot, not forgetting the photo booth to immortalize this
extraordinary evening.
It's not every day you turn 90: HAPPY BIRTHDAY
VETOQUINOL!
ABOUT VETOQUINOL Vetoquinol is a leading global animal
health company that supplies drugs and non-medicinal products for
the farm animals (cattle and pigs) and pet (dogs and cats) markets.
As an independent pure player, Vetoquinol designs, develops and
sells veterinary drugs and non-medicinal products in Europe, the
Americas and the Asia Pacific region. Since its foundation in 1933,
Vetoquinol has pursued a strategy combining innovation with
geographical diversification. The Group’s hybrid growth is driven
by the reinforcement of its product portfolio coupled with
acquisitions in high potential growth markets. Vetoquinol employed
more than 2,500 people as of December 31st, 2022. Vetoquinol has
been listed on Euronext Paris since 2006 (symbol: VETO). The
Vetoquinol share is eligible for the French PEA and PEA-PME
personal equity plans.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230619181273/en/
FOR MORE INFORMATION CONTACT:
VETOQUINOL
Group Communications Officer Resika Narain-Menigot
resika.narain-menigot@vetoquinol.com
KEIMA COMMUNICATION
Press Relations Charles-Edouard Aubry Tel.: +33
(0)6 09 09 48 32 charles-edouard.aubry@keima.fr
Investors Relations Emmanuel Dovergne Tel.: +33
(0)6 76 94 40 87 emmanuel.dovergne@keima.fr
Vetoquinol (EU:VETO)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Vetoquinol (EU:VETO)
Historical Stock Chart
Von Apr 2023 bis Apr 2024